Management of the infected hemodialysis access grafts.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D002339:Carotid Arteries / Q000637:transplantation*; D002417:Cattle; D003428:Cross Infection / Q000188:drug therapy*; D005263:Femoral Artery / Q000601:surgery; D005268:Femoral Vein / Q000601:surgery; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects*; D012501:Saphenous Vein / Q000601:surgery; D014183:Transplantation, Heterologous
D000900:Anti-Bacterial Agents